| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 6.34e-05 | 17 | 93 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 6.34e-05 | 17 | 93 | 3 | GO:0019198 | |
| GeneOntologyMolecularFunction | acid-amino acid ligase activity | 1.62e-04 | 23 | 93 | 3 | GO:0016881 | |
| Domain | TTL | 2.99e-05 | 13 | 90 | 3 | PS51221 | |
| Domain | TTL/TTLL_fam | 2.99e-05 | 13 | 90 | 3 | IPR004344 | |
| Domain | TTL | 2.99e-05 | 13 | 90 | 3 | PF03133 | |
| Domain | fn3 | 1.32e-04 | 162 | 90 | 6 | PF00041 | |
| Domain | FN3 | 2.72e-04 | 185 | 90 | 6 | SM00060 | |
| Domain | FN3 | 4.02e-04 | 199 | 90 | 6 | PS50853 | |
| Domain | ATP_grasp_subdomain_2 | 4.41e-04 | 31 | 90 | 3 | IPR013816 | |
| Domain | FN3_dom | 5.21e-04 | 209 | 90 | 6 | IPR003961 | |
| Domain | PTPc | 6.89e-04 | 36 | 90 | 3 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 8.72e-04 | 39 | 90 | 3 | PS50055 | |
| Domain | PTPase_domain | 1.01e-03 | 41 | 90 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 1.01e-03 | 41 | 90 | 3 | PF00102 | |
| Domain | Ig_I-set | 2.26e-03 | 190 | 90 | 5 | IPR013098 | |
| Domain | I-set | 2.26e-03 | 190 | 90 | 5 | PF07679 | |
| Domain | PTPc_motif | 2.89e-03 | 59 | 90 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 2.89e-03 | 59 | 90 | 3 | IPR003595 | |
| Domain | DUF1605 | 2.98e-03 | 17 | 90 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 2.98e-03 | 17 | 90 | 2 | PF07717 | |
| Domain | HA2 | 3.34e-03 | 18 | 90 | 2 | SM00847 | |
| Domain | HA2 | 3.34e-03 | 18 | 90 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 3.34e-03 | 18 | 90 | 2 | IPR007502 | |
| Domain | Fd_Rdtase_FAD-bd | 3.72e-03 | 19 | 90 | 2 | IPR017927 | |
| Domain | BAR | 3.72e-03 | 19 | 90 | 2 | PS51021 | |
| Domain | FAD_FR | 3.72e-03 | 19 | 90 | 2 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 3.72e-03 | 19 | 90 | 2 | IPR017938 | |
| Domain | Tyr_Pase_AS | 5.28e-03 | 73 | 90 | 3 | IPR016130 | |
| Pubmed | 7.08e-07 | 7 | 96 | 3 | 12376545 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MRPS31 DHX16 ATP6V1A RBM22 KIF23 POLR2A MRPS9 DUOX2 UPF3B GLOD4 CDC73 EMC8 NDUFA4 OLA1 HNRNPAB GOT2 | 1.74e-06 | 1425 | 96 | 16 | 30948266 |
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 4.40e-06 | 12 | 96 | 3 | 9624153 | |
| Pubmed | The noncatalytic domains of Lck regulate its dephosphorylation by CD45. | 7.54e-06 | 2 | 96 | 2 | 12922168 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 17897956 | ||
| Pubmed | Beta-selection of immature thymocytes is less dependent on CD45 tyrosinephosphatase. | 7.54e-06 | 2 | 96 | 2 | 9870664 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 25997448 | ||
| Pubmed | CD45 and RPTPalpha display different protein tyrosine phosphatase activities in T lymphocytes. | 7.54e-06 | 2 | 96 | 2 | 9581568 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 26210498 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 8663450 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 1695146 | ||
| Pubmed | Partial USH2A deletions contribute to Usher syndrome in Denmark. | 7.54e-06 | 2 | 96 | 2 | 25804404 | |
| Pubmed | Expression of the p56(Lck) Y505F mutation in CD45-deficient mice rescues thymocyte development. | 7.54e-06 | 2 | 96 | 2 | 10330160 | |
| Pubmed | CD45RO regulates the HIV-1 gp120-mediated apoptosis of T cells by activating Lck. | 7.54e-06 | 2 | 96 | 2 | 29549706 | |
| Pubmed | Membrane-cytoskeleton interactions in cholesterol-dependent domain formation. | 7.54e-06 | 2 | 96 | 2 | 25658353 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 15687496 | ||
| Pubmed | Demonstration of a direct interaction between p56lck and the cytoplasmic domain of CD45 in vitro. | 7.54e-06 | 2 | 96 | 2 | 8576115 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 9725213 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 7665159 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 33225946 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 18424699 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 24231767 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 25128530 | ||
| Pubmed | A Phosphosite within the SH2 Domain of Lck Regulates Its Activation by CD45. | 7.54e-06 | 2 | 96 | 2 | 28735895 | |
| Pubmed | Identification of intrinsic primary afferent neurons in mouse jejunum. | 7.54e-06 | 2 | 96 | 2 | 32986284 | |
| Pubmed | Cutting edge: the CD45 tyrosine phosphatase is an inhibitor of Lck activity in thymocytes. | 7.54e-06 | 2 | 96 | 2 | 9973453 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 15085197 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 14749125 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 8473339 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 9533446 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 11369760 | ||
| Pubmed | 9.27e-06 | 101 | 96 | 5 | 18519826 | ||
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | MRPS31 DMGDH VPS13D KIF23 ABCB7 TIMM21 POLG SELENOO MRPS9 GLOD4 NDUFA4 GADD45GIP1 GOT2 | 1.48e-05 | 1136 | 96 | 13 | 34800366 |
| Pubmed | CD45 down-regulates Lck-mediated CD44 signaling and modulates actin rearrangement in T cells. | 2.26e-05 | 3 | 96 | 2 | 18981123 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 12496362 | ||
| Pubmed | Regulation of Ly49D/DAP12 signal transduction by Src-family kinases and CD45. | 2.26e-05 | 3 | 96 | 2 | 16709819 | |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 2.26e-05 | 3 | 96 | 2 | 31985401 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 20139422 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 25703008 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 9784606 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 2.26e-05 | 3 | 96 | 2 | 33656439 | |
| Pubmed | CD45 regulation of tyrosine phosphorylation and enzyme activity of src family kinases. | 2.26e-05 | 3 | 96 | 2 | 8175795 | |
| Pubmed | Genome-wide association study of copy number variations (CNVs) with opioid dependence. | 2.26e-05 | 3 | 96 | 2 | 25345593 | |
| Pubmed | T/B lineage choice occurs prior to intrathymic Notch signaling. | 2.26e-05 | 3 | 96 | 2 | 15845899 | |
| Pubmed | Regulation of ATR activity via the RNA polymerase II associated factors CDC73 and PNUTS-PP1. | 2.26e-05 | 3 | 96 | 2 | 30541148 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 7507203 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 22990015 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 7499298 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 15661907 | ||
| Pubmed | Galectin-1, a natural ligand for the receptor-type protein tyrosine phosphatase CD45. | 2.26e-05 | 3 | 96 | 2 | 10369126 | |
| Pubmed | MRPS31 ADAMTS12 RBM22 ARMC3 TIMM21 ZNF658 LMLN ZBTB21 MRPS9 DGKA DUOX2 MYOM2 EMC8 HNRNPAB | 4.15e-05 | 1442 | 96 | 14 | 35575683 | |
| Pubmed | Klf4 glutamylation is required for cell reprogramming and early embryonic development in mice. | 4.49e-05 | 25 | 96 | 3 | 29593216 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 9573028 | ||
| Pubmed | Aurora A drives early signalling and vesicle dynamics during T-cell activation. | 4.51e-05 | 4 | 96 | 2 | 27091106 | |
| Pubmed | Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. | 4.51e-05 | 4 | 96 | 2 | 18463160 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 7807014 | ||
| Pubmed | Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling. | 4.51e-05 | 4 | 96 | 2 | 9403695 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 8524829 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 12589038 | ||
| Pubmed | Substrate specificities and activities of AZAP family Arf GAPs in vivo. | 4.51e-05 | 4 | 96 | 2 | 18003747 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 12100025 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 12560083 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MRPS31 ATP6V1A VPS11 ABCB7 ATP2C1 HEATR6 MRPS9 OLA1 C1orf50 DIPK2A | 4.56e-05 | 754 | 96 | 10 | 33060197 |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 6.97e-05 | 364 | 96 | 7 | 24778252 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 12244310 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 10777529 | ||
| Pubmed | Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis. | 7.50e-05 | 5 | 96 | 2 | 27986797 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 22357843 | ||
| Pubmed | Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2. | 7.50e-05 | 5 | 96 | 2 | 16301216 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 8570203 | ||
| Pubmed | Selective regulation of Lyn tyrosine kinase by CD45 in immature B cells. | 7.50e-05 | 5 | 96 | 2 | 7499277 | |
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 19273906 | ||
| Pubmed | Characterization of Lnk. An adaptor protein expressed in lymphocytes. | 1.12e-04 | 6 | 96 | 2 | 9169414 | |
| Pubmed | 1.32e-04 | 542 | 96 | 8 | 14651853 | ||
| Pubmed | 1.57e-04 | 7 | 96 | 2 | 29073098 | ||
| Pubmed | 1.57e-04 | 7 | 96 | 2 | 1454056 | ||
| Pubmed | 1.57e-04 | 7 | 96 | 2 | 26659056 | ||
| Pubmed | 1.57e-04 | 7 | 96 | 2 | 20058854 | ||
| Pubmed | Subdomain X of the kinase domain of Lck binds CD45 and facilitates dephosphorylation. | 1.57e-04 | 7 | 96 | 2 | 14625311 | |
| Pubmed | The parafibromin tumor suppressor protein is part of a human Paf1 complex. | 1.57e-04 | 7 | 96 | 2 | 15632063 | |
| Pubmed | BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A. | 1.66e-04 | 419 | 96 | 7 | 33001583 | |
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 2.09e-04 | 8 | 96 | 2 | 19683999 | |
| Pubmed | 2.09e-04 | 8 | 96 | 2 | 18484607 | ||
| Pubmed | 2.09e-04 | 8 | 96 | 2 | 37591863 | ||
| Pubmed | 2.09e-04 | 8 | 96 | 2 | 16545802 | ||
| Pubmed | 2.09e-04 | 8 | 96 | 2 | 28637841 | ||
| Pubmed | 2.62e-04 | 204 | 96 | 5 | 25659154 | ||
| Pubmed | 2.68e-04 | 9 | 96 | 2 | 20178742 | ||
| Pubmed | Elongation factor 1 alpha1 and genes associated with Usher syndromes are downstream targets of GBX2. | 2.68e-04 | 9 | 96 | 2 | 23144817 | |
| Pubmed | Genetic modifiers of muscular dystrophy: implications for therapy. | 2.68e-04 | 9 | 96 | 2 | 16916601 | |
| Pubmed | The human PAF complex coordinates transcription with events downstream of RNA synthesis. | 2.68e-04 | 9 | 96 | 2 | 16024656 | |
| Pubmed | 2.68e-04 | 9 | 96 | 2 | 15923622 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | JPH1 ATP6V1A ATP2C1 PTPRF TIMM21 CYP51A1 EMC8 MAPRE2 CEP97 DIPK2A | 2.79e-04 | 942 | 96 | 10 | 31073040 |
| Pubmed | Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1. | 3.34e-04 | 10 | 96 | 2 | 24618850 | |
| Pubmed | 3.34e-04 | 10 | 96 | 2 | 24239741 | ||
| Pubmed | Real-time resolution of point mutations that cause phenovariance in mice. | 3.34e-04 | 10 | 96 | 2 | 25605905 | |
| Pubmed | 3.34e-04 | 10 | 96 | 2 | 23437001 | ||
| Pubmed | 3.42e-04 | 472 | 96 | 7 | 38943005 | ||
| Pubmed | 3.86e-04 | 51 | 96 | 3 | 19164599 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 4.00e-04 | 807 | 96 | 9 | 22681889 | |
| GeneFamily | Tubulin tyrosine ligase family | 1.50e-05 | 14 | 64 | 3 | 779 | |
| GeneFamily | Fibronectin type III domain containing | 2.15e-05 | 160 | 64 | 6 | 555 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 5.38e-05 | 21 | 64 | 3 | 813 | |
| GeneFamily | DEAH-box helicases | 1.43e-03 | 16 | 64 | 2 | 500 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.54e-03 | 161 | 64 | 4 | 593 | |
| GeneFamily | T cell receptor beta locus at 7q34 | 3.63e-03 | 87 | 64 | 3 | 372 | |
| ToppCell | COVID-19-T_cells-NK_cells|COVID-19 / group, cell type (main and fine annotations) | 3.44e-06 | 189 | 96 | 6 | b699152dfbb8cd8ed724e1e5a51838f29b681b62 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-06 | 194 | 96 | 6 | 37803f4abf1aa1ad771c9cd293933003d7101e70 | |
| ToppCell | droplet-Tongue|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-06 | 195 | 96 | 6 | e460b09ae354b579ce552acebdaa5877a6e62343 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.24e-06 | 196 | 96 | 6 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.36e-06 | 197 | 96 | 6 | 861e8df9bd74dc5e17bafdc1fb3fef546753c73a | |
| ToppCell | Skin|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 4.62e-06 | 199 | 96 | 6 | 6be1340413ee868c610b6e3f58c65b493eb22bb5 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.62e-06 | 199 | 96 | 6 | ba284f984909504221900bca5ea12ada5b2ffd9f | |
| ToppCell | Biopsy_IPF-Epithelial-Basal|Biopsy_IPF / Sample group, Lineage and Cell type | 4.76e-06 | 200 | 96 | 6 | 5cea84581201cee7ba8141b96e65864f4fd67113 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 139 | 96 | 5 | 22a769d5195ed761ef333ef542746e1ba617a698 | |
| ToppCell | facs-Aorta-Heart-3m-Myeloid-professional_antigen_presenting_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 139 | 96 | 5 | 292533e04178dd36d57377562077f9deb2cb9746 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 151 | 96 | 5 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.90e-05 | 151 | 96 | 5 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 155 | 96 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-05 | 155 | 96 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 157 | 96 | 5 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-T_entry|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.67e-05 | 162 | 96 | 5 | a27750117e7f16a0bd07cc5f58a56becb39e800b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.76e-05 | 174 | 96 | 5 | e2243f1e48e3275753a2b3a69d06eefce69a8ded | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.30e-05 | 179 | 96 | 5 | ca70a5518c5a5392e088c103e0cb44aa084f5332 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.30e-05 | 179 | 96 | 5 | c451b074b04eb5d6c575c6abaedda579c6744bbf | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-05 | 182 | 96 | 5 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-05 | 182 | 96 | 5 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.90e-05 | 184 | 96 | 5 | 45ff845ceed5960a997545c1009012b65e377d50 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.90e-05 | 184 | 96 | 5 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.90e-05 | 184 | 96 | 5 | 2cc2646dee3c6001f7c10b7449c17d1935021958 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.16e-05 | 186 | 96 | 5 | 165d02be3b3eaeb8784a2b0b2020928b21a19bc7 | |
| ToppCell | facs-Lung-18m-Epithelial-alveolar_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.16e-05 | 186 | 96 | 5 | c7214e762b3b48197fdd0b36a50a4de2550a888f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.43e-05 | 188 | 96 | 5 | e5c480b9a030536578f1cc91fb61738f752525b3 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.56e-05 | 189 | 96 | 5 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | IPF-Lymphoid-NK|IPF / Disease state, Lineage and Cell class | 5.56e-05 | 189 | 96 | 5 | d92e880162450f8d01e4b8784eb625275cb8e03e | |
| ToppCell | droplet-Lung-nan-18m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-05 | 190 | 96 | 5 | b057bea6e55cef872290893b6e439bbcdcee2f2e | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.85e-05 | 191 | 96 | 5 | c5e22df4a8741b8096cdd1618271fd48d6265846 | |
| ToppCell | facs-Skin|facs / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 191 | 96 | 5 | ae524103331fa53fa82888dbb567fc36abcee7e0 | |
| ToppCell | droplet-Lung-18m-Epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.85e-05 | 191 | 96 | 5 | 1b59f1cad6c1a6a5938afa9195164918e3ff4e86 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.99e-05 | 192 | 96 | 5 | a06d5d3c2537f8d2b1dc6b6f3e88a80b5c2a1850 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.14e-05 | 193 | 96 | 5 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | background-NK_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 6.14e-05 | 193 | 96 | 5 | f8d6eff1e04926f85d265ec39fe66897fe29574d | |
| ToppCell | E16.5-samps-Epithelial-Alveolar_epithelial_precursor|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.14e-05 | 193 | 96 | 5 | c1817ad675b9f9d2d3436c8b9646edf89f0d4c82 | |
| ToppCell | E16.5-samps-Epithelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.14e-05 | 193 | 96 | 5 | 1cb5a1cffa2b4a3bfecca16b791c1992edeb237d | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.14e-05 | 193 | 96 | 5 | 1cb666375bc4e1b11a146d20896c9b5ae6fd0887 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 6.45e-05 | 195 | 96 | 5 | e91e7f89163c615b706f3297b641b1e4c966f5e6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.45e-05 | 195 | 96 | 5 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 6.45e-05 | 195 | 96 | 5 | a5a10ef9254c266316e5591bec19e159cc3caead | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-05 | 196 | 96 | 5 | c5adab88140a465698abcbedc6505a43cae7bfd1 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.61e-05 | 196 | 96 | 5 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.77e-05 | 197 | 96 | 5 | 8623972c7a70b3565b7a3a4afe93f1e012008201 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 6.77e-05 | 197 | 96 | 5 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.77e-05 | 197 | 96 | 5 | de772bd2b4cda843777ac879b1087e6444199dfb | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.77e-05 | 197 | 96 | 5 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.77e-05 | 197 | 96 | 5 | 9ee927d005eb17843e2516c8006eb192c6ad2af8 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.93e-05 | 198 | 96 | 5 | de5987588b9fa9ee8c595ba06d7d844ead0e3c74 | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 6.93e-05 | 198 | 96 | 5 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Reg_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.93e-05 | 198 | 96 | 5 | 3371276410dba693c238b383d990b89371b14d8d | |
| ToppCell | distal-Hematologic-CD4+_Memory/Effector_T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.93e-05 | 198 | 96 | 5 | 7a89635f3567b4d2e6cd684c47be2e015d72a357 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.93e-05 | 198 | 96 | 5 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 198 | 96 | 5 | e2d1ef4a4c89ce53b47d7d5b8a45e71d3117e1b1 | |
| ToppCell | droplet-Skin-nan-21m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 198 | 96 | 5 | 38a58e6eaae89ce1cadf2e04169c974e13587e50 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.10e-05 | 199 | 96 | 5 | 995d710d7302272e7951a5a5d766d1039089ee2b | |
| ToppCell | PSB-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.10e-05 | 199 | 96 | 5 | 2add64c3e4cb6384ec381f34c3f1f77e13e3f27c | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.10e-05 | 199 | 96 | 5 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.10e-05 | 199 | 96 | 5 | 8649c2380285a668782d75eb076ce548eed0911d | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.27e-05 | 200 | 96 | 5 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Tracheal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | efd461c687155c84ef590352207e6fe4ba392a90 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 7.27e-05 | 200 | 96 | 5 | 592c7c3ded409a9957cbcdc62fcc213fa8eae598 | |
| ToppCell | Biopsy_Other_PF-Epithelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 7.27e-05 | 200 | 96 | 5 | 1ef4d5ae698fa721e0f510bf0d918bd8d3b00591 | |
| ToppCell | Skin-Keratinocytes|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 7.27e-05 | 200 | 96 | 5 | 59d72395199bc30df0e811fbc99149694e208860 | |
| ToppCell | Biopsy_Other_PF-Immune-NK_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 7.27e-05 | 200 | 96 | 5 | 418d665b8431697fc9e516258c9fe374257750d9 | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | d1cfc4ef6ae75c486427e393d98b84a2a7ec67fe | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | 0a6fc7eff94e2f71af9f31a01779aafd2f4a6699 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.27e-05 | 200 | 96 | 5 | 8cfbde43c5e66269ad128aa5398b1517667d7d36 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Cilia-bearing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 7.27e-05 | 200 | 96 | 5 | 177f9ad8dd8635394c575a2b30140184df0bd51e | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.27e-05 | 200 | 96 | 5 | 61811380d9252f12f27b7ad4752380b52692677f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|ILC / Donor, Lineage, Cell class and subclass (all cells) | 1.25e-04 | 8 | 96 | 2 | 7e2e4c7bacc88c7bee10751805cb4caaf9da6aee | |
| ToppCell | Lymphoid-T_cells_(Cd4+_Tnaive-Tcm)|World / shred on cell class and cell subclass (v4) | 1.91e-04 | 132 | 96 | 4 | 14a371fc7e47a45b84f10a939163d030ad967de5 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.02e-04 | 134 | 96 | 4 | a3547a68012d879d4dfe80394eace70808722e43 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.02e-04 | 134 | 96 | 4 | 9458e2d0dbc18d9025b66b59f3ecc2fbc5384940 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-04 | 143 | 96 | 4 | b4ed3855652fdf32f97cb7c18cab4f4f4c24d5c7 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.73e-04 | 145 | 96 | 4 | 88e463d5396a8fea2b7b1ecf3c9b144e16b35234 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.73e-04 | 145 | 96 | 4 | 911fee7f27694393e348d94470a1a4e890038902 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.88e-04 | 147 | 96 | 4 | aba44c7057096483c4293a7ebcf8ccc8baed0231 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_and_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.03e-04 | 149 | 96 | 4 | 3904f8ce9078de238600ceceee0116af52256a1c | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.19e-04 | 151 | 96 | 4 | b698ddc74565d47892c09c3f16d78038da2dd5e7 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.19e-04 | 151 | 96 | 4 | 512f7f37ddc8dfa1906f7fff92b571929236c9ea | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.19e-04 | 151 | 96 | 4 | 75c068b3e3aae5f9ba64d5fa5d1e2105a60e4293 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-04 | 151 | 96 | 4 | f4f7156b2c0cfc78fd1841e07c9915d97ced561f | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.27e-04 | 152 | 96 | 4 | 00d5503d462cfa009fb4cac79ecee11725a18b9a | |
| ToppCell | COVID-19_Severe-CD8+_T_naive|World / disease group, cell group and cell class | 3.43e-04 | 154 | 96 | 4 | b568417d88a78d8c46688847f0f5f4989bd36387 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.43e-04 | 154 | 96 | 4 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.43e-04 | 154 | 96 | 4 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | facs-BAT-Fat-24m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 155 | 96 | 4 | 550e7e7e52829244ead829e5be010bfdc71e2ba5 | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-04 | 156 | 96 | 4 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.61e-04 | 156 | 96 | 4 | d411116d54add2d4fe649a97ac54cb94c085312f | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.69e-04 | 157 | 96 | 4 | 542944030cd9b3f3559e64f9f6598694d74003c0 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.87e-04 | 159 | 96 | 4 | e9c51e611ebd427bbe51e3e036c14122c36ea372 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.87e-04 | 159 | 96 | 4 | 8d958d79f5eb3ab683d1245ae7f4f22a2cefbc55 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-04 | 159 | 96 | 4 | 9f6607e395bcca9cb1c83199bdbbaaa62a93938d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-04 | 159 | 96 | 4 | c8b42ebc25ebcc450832096fbffaa5c5f5fe88e7 | |
| ToppCell | E16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.97e-04 | 160 | 96 | 4 | b2d8940ea8c068273b7da1589d3d6ae5110d8209 | |
| Disease | non-alcoholic fatty liver disease severity measurement | 8.51e-05 | 28 | 90 | 3 | EFO_0008421 | |
| Disease | Usher Syndrome, Type II | 9.15e-05 | 5 | 90 | 2 | C1568249 | |
| Disease | thrombin-antithrombin complex measurement | 5.95e-04 | 12 | 90 | 2 | EFO_0007775 | |
| Disease | Opioid use measurement | 9.41e-04 | 15 | 90 | 2 | EFO_0009937 | |
| Disease | stroke | 1.00e-03 | 144 | 90 | 4 | EFO_0000712 | |
| Disease | decreased susceptibility to hepatitis C infection | 1.07e-03 | 16 | 90 | 2 | EFO_0010101 | |
| Disease | obesity (biomarker_via_orthology) | 1.08e-03 | 147 | 90 | 4 | DOID:9970 (biomarker_via_orthology) | |
| Disease | androstenedione measurement, estrone measurement | 1.36e-03 | 18 | 90 | 2 | EFO_0007970, EFO_0007972 | |
| Disease | Feeding difficulties | 1.36e-03 | 18 | 90 | 2 | C0232466 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DFDNQKVYAVYRGPE | 31 | Q7L4P6 | |
| DQIKYYRNNPGQDGR | 261 | Q8NEM8 | |
| YVNYCNPELNQAGKG | 196 | Q6ZW13 | |
| IPAAYNRYDQERFKG | 286 | Q6P1J9 | |
| LAEAQGQKGYVPANY | 756 | Q9NXL2 | |
| NIINDGFYDYGRINP | 566 | Q5W041 | |
| LYGQPGDETYQDIFR | 741 | Q15057 | |
| QIPQYLFEEGYTNKG | 431 | O60231 | |
| GLQQDYIRKAEYPFS | 441 | P98194 | |
| EDPEKYYLNGGFIIQ | 746 | P58397 | |
| GQNYYKEGPEGNDIR | 716 | Q01432 | |
| DILQGYPKDISNYGF | 356 | P22894 | |
| KRPFGQSFVYIYDNG | 676 | Q6ZS30 | |
| QNIKDRYYGINDPVA | 196 | Q9NW64 | |
| YQGPQKEPDDYSNFV | 786 | Q15283 | |
| GKYRQQGRNYIVEDG | 366 | Q9NTK5 | |
| LQGGARVIFDDYKPY | 6 | Q96TA0 | |
| NPYFNSLEQKDLVGY | 576 | P56975 | |
| GEPAKFYGYDNLQRQ | 131 | P13378 | |
| QKNPDSYNGAVRENY | 176 | Q8IVD9 | |
| ETEAPGGYKFYLQNR | 131 | Q9HC38 | |
| YVPGEGYNQKFRELY | 231 | O00180 | |
| NQPEIFKNYGAEKYG | 506 | Q96KR4 | |
| FYQPGPDYVKQRFQE | 416 | Q9HDC5 | |
| YLQFQRPQGFEYKSG | 1286 | Q9NRD8 | |
| KYVQGDAIGYEGFQQ | 41 | P23743 | |
| AKIFNYGRIYGAGQP | 946 | P54098 | |
| VPGKREQYGSVDQYA | 1026 | Q6AI08 | |
| YRPIDYGIFGKEQQL | 1881 | Q8NEV8 | |
| YKIRNLDNGGFYISP | 181 | P06239 | |
| RVDLYIKINQNFPGY | 561 | Q96M69 | |
| NSQLIRYAGYKQPDG | 481 | P29475 | |
| SAEPKGNEYGRNYFD | 81 | Q8IZS5 | |
| DINKDFQPYYGEGGR | 1336 | Q96QU1 | |
| GYVFLDNKGQEYPAI | 116 | Q9BZI7 | |
| YGGQDVFLNNKYDRA | 336 | A8MW95 | |
| ELEGYLQKQPYFGAV | 61 | Q96C23 | |
| NENGDAPGRYDIFQY | 461 | O15303 | |
| NGYKAYDPENRNGNG | 491 | Q14574 | |
| QDGKPYYAQIRGFIQ | 161 | Q8WUU5 | |
| GYIKNPYNIFDGVIV | 801 | O43497 | |
| GFKARYPAVDYNLVQ | 631 | O00548 | |
| GFYARNYNPQAKDVR | 571 | Q8IW35 | |
| GKEYVLNRNRYGVEP | 146 | A6NCJ1 | |
| LNVKNVYFAQYGEPR | 86 | Q8NDZ4 | |
| RYLQDNPASGEKFAY | 431 | Q16850 | |
| DPQEQLYKAYTGFEQ | 161 | O43820 | |
| GKNYQNGDVFGDEYR | 21 | Q9H246 | |
| QYFNGAPVLYLEGRQ | 241 | Q9H6R0 | |
| GFQGQQYILERGEYP | 61 | P53673 | |
| RESYGFNNIVGYPKE | 446 | Q9UI17 | |
| FNNIVGYPKEERFAG | 451 | Q9UI17 | |
| NYDGKEYDPVEARQG | 161 | Q15555 | |
| FLGPQNKETGRVYVY | 511 | O75578 | |
| QLGPRYAAKQFARYG | 51 | Q8TAE8 | |
| GYYQANERVKDASPN | 91 | O43402 | |
| PDAGRYYVQAVNDKN | 176 | Q58EX2 | |
| PGNIYYLYKRESGQQ | 116 | Q9BV19 | |
| DGYRQQKAYIATQGP | 1701 | P10586 | |
| DGYRQQKAYIATQGP | 1706 | P23468 | |
| DRQVPGGYTVINKYQ | 236 | Q93099 | |
| TPEGYRLNRNGDYKE | 56 | Q02241 | |
| IQFDEGYDNYPGQEK | 226 | Q92665 | |
| YNDKPFRQGDQVYAF | 556 | O75445 | |
| YRPFYVNKGNGIGSN | 571 | Q14134 | |
| PKEVYQQQQYGSGGR | 231 | Q99729 | |
| LSNDEYYFPKQQGLR | 586 | Q8IZX4 | |
| YANENPGDFVNYNKR | 656 | Q9UPR0 | |
| LGPNDQYKFYSVNVD | 56 | O00483 | |
| VVRDVFYDGNPKYEQ | 226 | Q9BVL4 | |
| YSLEEPKQANGGAYQ | 286 | P18827 | |
| ERPENQYVYKIGIYG | 16 | Q13326 | |
| FYEPQKGSIYLAGQN | 521 | O75027 | |
| NLGVGAYRDDNGKPY | 61 | P00505 | |
| EGKYRRYHPLFGNQE | 646 | Q96P48 | |
| RSFYRQNGEPYIGKV | 606 | O75339 | |
| GPQFIFQYYEKEERG | 61 | A0A597 | |
| FQYYEKEERGRGNFP | 66 | A0A597 | |
| NKGNGQGEDRNLLYY | 296 | Q9ULJ3 | |
| QDGVLYLYEQGKLFQ | 676 | Q9H270 | |
| GRIKVNGIDYQLYFP | 291 | P82933 | |
| SQYPGAKYIIRDNGD | 411 | P24928 | |
| QGNPYFRNEGLVKEY | 301 | Q9UJ04 | |
| KDDFLQQNGYTPYDR | 516 | P38606 | |
| GPQFIFQYYEKEERG | 61 | A0A0A0MS05 | |
| FQYYEKEERGRGNFP | 66 | A0A0A0MS05 | |
| GPQFIFQYYREEENG | 61 | A0A0C4DH59 | |
| FQYYREEENGRGNFP | 66 | A0A0C4DH59 | |
| RLYNQGKPVNFDDYG | 276 | P85298 | |
| LQAKGRVFRNPYNYG | 311 | Q969W1 | |
| QVKENPGSGEYDFRY | 211 | Q9BVV7 | |
| DEFLNQRYPGYFKVD | 71 | Q5TYW1 | |
| QRYIENPYLIGGRKF | 211 | Q3SXZ7 | |
| PYDQEELKNRYQSFG | 81 | P19224 | |
| NYINASYIDGFKEPR | 706 | P08575 | |
| PGLVQLVNYYRGADK | 56 | Q8NG68 | |
| PADYGDFQSYGRQRK | 181 | A6NNM8 | |
| QGGTPIRYYFENLKI | 3976 | Q5THJ4 | |
| FYINEVGGQPYKLPN | 121 | Q8NHV5 | |
| QGYILDGFPKTYDQA | 476 | Q96M32 | |
| QAAEPGKYRIESNYG | 196 | P54296 |